RxDoctor Payments DataLook up a doctor →

FIBRYGA & BALFAXAR: payments to doctors

Payments that named FIBRYGA & BALFAXAR as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$217K
Providers
49
Transactions
383
Average per transaction
$567

The per-transaction average — $567 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 49 providers the average total is $4,429, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Octapharma USA, Inc.$217,011100.0%
← All drugs & devices